semaglutide binge eating disorder disorders rise amid popular weight loss medications Wegovy and Zepbound—Is there a link? Beyond weight loss: Integrating GLP-1

Over the course of the next 3 to 5 years several groups demonstrated the correctness of this hypothesis by demonstrating that MTC produces calcitonin (9,10) and that measurement of CT could be used to diagnose MTC (11)

When Alternative Compounds May Serve You Better Tirzepatide (dual GLP-1/GIP agonist) produces greater mean weight loss than semaglutide in head-to-head trialsapproximately 22% versus 14% at comparable dosesand may suit individuals who tolerate GLP-1 poorly or require more aggressive metabolic support

Energize your journey with B12 injections

Nausea may increase for some individuals during this period

(2020) 9:e00507

[Google Scholar] Marx N, Kolkailah AA, Rosenstock J